SARS-CoV-2 vaccination induces mucosal antibody responses in | ResearchBunny

Index

Abstract

This study analyzes serum and saliva samples from individuals with and without prior COVID-19 infection before and after mRNA vaccination. The results suggest that mRNA vaccination induces more robust mucosal secretory IgA (SIgA) responses in individuals with prior SARS-CoV-2 exposure. SIgA induction post-vaccination was more efficient in those with a history of COVID-19.

Publisher

Nature Communications

Published On

Sep 01, 2022

Authors

Kaori Sano, Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason, PARIS Study Group, Juan Manuel Carreño, Viviana Simon, Florian Krammer

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice

A. S. Ashhurst, M. D. Johansen, et al.

Medicine and Health

Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2

V. Garcia-flores, R. Romero, et al.

Medicine and Health

Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages

M. Chernychev, M. Sakharkar, et al.

Medicine and Health

SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates

E. A. Murphy, C. Guzman-cardozo, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs—just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny